Nine years after my bladder cancer diagnosis, I reflect on its recurrence, caregiving, grief, and my new life with leukemia and renewed gratitude.

The FDA has granted RMAT designation to detalimogene voraplasmid for the treatment of high-risk, BCG-unresponsive, NMIBC with CIS.

As it is mainly a diagnosis of exclusion, urinalyses, urodynamics, cystoscopy with bladder distension and bladder biopsy are commonly performed investigations, although their relevance and ...

Given a surge in cancers such as prostate, bladder, kidney, and testicular, experts urge men to take the symptoms seriously and undergo routine screening  There is an alarming rise in urological ...

Frequent cystoscopy for monitoring nonmuscle-invasive bladder cancer (NMIBC) is burdensome and costly, prompting a search for alternatives.

Bladder cancer is a difficult disease to manage and requires long-term follow-up after treatment including the use of cystoscopy for detecting recurrence. In this Review the role of ...

A trans urethral resection of bladder tumour (TURBT) is usually the first treatment you have for non muscle invasive bladder cancer. The surgeon puts a thin rigid tube called a cystoscope into your ...

Discover a study exploring novel drug combinations and genetic insights transforming advanced bladder cancer treatment.

Chemotherapy used to target and kill bladder cancer cells may trigger an inflammatory response that ultimately may make the ...

Treatment for non muscle invasive bladder cancer usually includes having surgery called a trans urethral resection of bladder tumour (TURBT). But you may need more treatment after surgery.